The collection of Bathynellacea specimens of MNCN (CSIC) Madrid: microscope slices and DNA extract.

Zookeys

Department of Collection, Museo Nacional de Ciencias Naturales, CSIC, c/José Gutiérrez Abascal nº2, 28006, Madrid, Spain.

Published: June 2017

This is the first published database of a Bathynellacea Chappuis, 1915 collection of slices and DNA extracts. It includes all data of bathynellaceans (Crustacea: Syncarida) collected in the last 48 years (1968 to 2016) on the Iberian Peninsula and Balearic Islands, studied since 1984. It also includes specimens studied across many countries of Europe (Portugal, Romania, France, Italy, Slovenia, Bulgaria, and England), as well as some specimens obtained from samples of North America (Montana, Washington, Alaska and Texas), South America (Brazil, Chile and Argentina), Asia (China, Thailand, Vietnam, Mongolia and India), Africa (Morocco and Chad) and Australia (New South Wales -NSW- and Queensland). The samples come from groundwater (caves, springs, wells and hyporrheic habitat associated with rivers) obtained from both, sampling campaigns and occasional sampling efforts. The data set includes 3399 records (2657 slices and 742 DNA extracts) corresponding to three families (Parabathynellidae Noodt, 1965, Leptobathynellidae Noodt, 1965 and Bathynellidae Grobben, 1905) of the order Bathynellacea; ; 52 genera and 92 species formally described, in addition to 30 taxa under study and, thus, still unpublished. This represents more than half of all the genera known worldwide (80) and almost one third of the species currently known in the world (329, which increases every year). This dataset contains especially relevant collection that includes holotypes and type series of 43 new species of Bathynellacea (33 from the Parabathynellidae and ten from the Bathynellidae) described by Ana I. Camacho (AIC hereinafter); eleven of these are the type species for new genera described from all around the world, ten belonging to the Parabathynellidae and one from the Bathynellidae. As previously mentioned, these new species come from all continents, although 26 of them are from the Iberian Peninsula. The most important feature of this collection is that it has been created and reviewed by a specialist of the group (AIC), and each specimen, regardless of its shape (either permanent slices or DNA extracts), includes taxonomic, geographical and authorship information. The specialist has been involved in all stages of the process, from field sampling to the digitization of the results we are now presenting, and has worked in close collaboration with the curators responsible for the different collections involved in this project.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523361PMC
http://dx.doi.org/10.3897/zookeys.678.11543DOI Listing

Publication Analysis

Top Keywords

slices dna
12
dna extracts
12
extracts includes
8
iberian peninsula
8
noodt 1965
8
includes
5
species
5
collection
4
collection bathynellacea
4
bathynellacea specimens
4

Similar Publications

Skeletal remains are the only source of the genetic material of decomposed organisms or once-lived species. Unlike, soft tissues they are highly mineralized, and their anatomical and morphological structure prevents their deformation in the presence of adverse environmental factors. Therefore, bones and teeth protect the Deoxyribonucleic Acid (DNA) inside them.

View Article and Find Full Text PDF

BRAT1 - a new therapeutic target for glioblastoma.

Cell Mol Life Sci

January 2025

Experimental Neurosurgery, Department of Neurosurgery, Neuroscience Center, Goethe University Hospital, Goethe University Frankfurt, 60528, Frankfurt am Main, Germany.

Glioblastoma (GBM), the most malignant primary brain tumor in adults, has poor prognosis irrespective of therapeutic advances due to its radio-resistance and infiltrative growth into brain tissue. The present study assessed functions and putative druggability of BRCA1-associated ATM activator 1 (BRAT1) as a crucial factor driving key aspects of GBM, including enhanced DNA damage response and tumor migration. By a stable depletion of BRAT1 in GBM and glioma stem-like (GSC) cell lines, we observed a delay in DNA double-strand break repair and increased sensitivity to radiation treatment, corroborated by in vitro and in vivo studies demonstrating impaired tumor growth and invasion.

View Article and Find Full Text PDF

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures.

J Vis Exp

December 2024

The David and Inez Myers Laboratory for Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, Faculty of Health and Medical Sciences, School of Medicine, Tel Aviv University;

Cerebellar Purkinje cells (PCs) exhibit a unique interplay of high metabolic rates, specific chromatin architecture, and extensive transcriptional activity, making them particularly vulnerable to DNA damage. This necessitates an efficient DNA damage response (DDR) to prevent cerebellar degeneration, often initiated by PC dysfunction or loss. A notable example is the genome instability syndrome, ataxia-telangiectasia (A-T), marked by progressive PC depletion and cerebellar deterioration.

View Article and Find Full Text PDF

Identification of key genes related to growth of largemouth bass () based on comprehensive transcriptome analysis.

Front Mol Biosci

December 2024

State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Institute of Hydrobiology, Zhejiang Academy of Agricultural Sciences, Hangzhou, China.

Introduction: Largemouth bass is an economically important farmed freshwater fish species that has delicious meat, no intermuscular thorns, and rapid growth rates. However, the molecular regulatory mechanisms underlying the different growth and developmental stages of this fish have not been reported.

Methods: In this study, we performed histological and transcriptomic analyses on the brain and dorsal muscles of largemouth bass at different growth periods.

View Article and Find Full Text PDF

Background: There is increasing interest in enhancing the response of the PARP inhibitor olaparib, which is currently approved for pancreatic ductal adenocarcinoma (PDAC) patients with defects in DNA damage repair associated with germline BRCA1/2 mutations. Moreover, agents that can mimic these defects in the absence of germline BRCA1/2 mutations are an area of active research in hopes of increasing the number of patients eligible for treatment with PARP inhibitors. The extent to which regorafenib, an FDA-approved tyrosine kinase inhibitor, can be used to enhance the efficacy of PARP inhibitors in PDAC cells without known BRCA1/2 mutations remains to be investigated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!